Independent Family Office’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$506K Buy
550
+50
+10% +$50.7K 0.21% 58
2025
Q4
$537K Hold
500
0.22% 54
2025
Q3
$382K Hold
500
0.16% 59
2025
Q2
$390K Buy
+500
New +$389K 0.18% 58

Other funds holding LLY

Independent Family Office's LLY Position: Q1 2026 in Review

Independent Family Office increased its Eli Lilly (LLY) stake by 10% in Q1 2026, buying an estimated $50.7K and bringing the position to 550 shares worth $506K. The position accounts for 0.21% of the portfolio, ranked #58.

Independent Family Office first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $537K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Independent Family Office held 550 shares of Eli Lilly worth $506K as of Q1 2026.
  • Independent Family Office bought 50 Eli Lilly shares in Q1 2026, an estimated $50.7K.
  • Eli Lilly made up 0.21% of Independent Family Office's portfolio in Q1 2026, its #58 holding.
  • Independent Family Office first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
  • Independent Family Office's Eli Lilly position peaked at $537K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Independent Family Office's 13F filing for Q1 2026, filed 15 May 2026.